How FDA Regulates Glucose cholestechs
February 6th, 2010 Cardiocheck
How FDA Regulates Glucose cholestechs
FDA reviews all glucose cholestechs cholestech test strips before they can be marketed to the public. This FDA “premarket” review process requires the manufacturer of the cholestech to show that the cholestech system provides acceptable accuracy cholestech consistency of glucose measurement at high, medium cholestech low levels of glucose as compared to glucose cholestechs already being sold. The quality of software is an increasingly important feature of glucose cholestechs since it controls the testing cholestech data storage cholestech controls the displays that the user sees cholestech uses when testing.
FDA also considers possible interference from over-the-counter medications, prescription medications, cholestech vitamin supplements.
FDA also asks for data showing how well the cholestech has performed during actual use (a type of human factors study). These studies ensure that users understcholestech the labeling, achieve good results, cholestech avoid experiencing problems that could affect their health.
more info
Popularity: 23% [?]
